7,999 Call Contracts Traded on Divis Laboratories Ltd as Stock Nears 52-Week High

2 hours ago
share
Share Via
On 25 Aug 2026, 7,999 call contracts on Divis Laboratories Ltd changed hands at the Rs 8,700 strike, while the stock closed at Rs 8,599.50, just 0.9% shy of its 52-week high. This close alignment between the options strike and the underlying price highlights a focused directional bet in the near term.
7,999 Call Contracts Traded on Divis Laboratories Ltd as Stock Nears 52-Week High

Options Event and Cash Market Price Action

The call option activity on Divis Laboratories Ltd was concentrated at the Rs 8,700 strike price, with 7,999 contracts traded on the day of expiry, 25 Aug 2026. The turnover for these contracts was approximately ₹87.03 lakhs, signalling significant interest in this strike. The underlying stock closed at Rs 8,599.50, just below the strike, indicating that these calls are slightly out-of-the-money but very close to at-the-money territory. The stock outperformed its sector by 1.03% and gained 1.25% on the day, reinforcing the bullish undertone in both cash and derivatives markets. Divis Laboratories Ltd is trading near its 52-week high of Rs 8,674, which adds further context to the options activity — is this a sign of sustained momentum or a peak in short-term optimism?

Strike Price and Moneyness Analysis

The Rs 8,700 strike is effectively at-the-money given the underlying price of Rs 8,599.50, making these calls highly sensitive to immediate price movements. At-the-money options carry the highest gamma, meaning small changes in the stock price can lead to significant changes in option value. This suggests that the market participants are positioning for a near-term directional move rather than a distant speculative target. The proximity to the 52-week high further emphasises that the strike price reflects a critical resistance level, where traders are either betting on a breakout or hedging against a potential reversal. what does this precise strike selection reveal about market conviction?

Open Interest and Contracts Analysis

Open interest at the Rs 8,700 strike stood at 1,090 contracts before the trading day, while 7,999 contracts were traded on expiry day. This results in a contracts-to-open interest ratio of approximately 7.3:1, a notably high figure that indicates predominantly fresh positioning rather than the recycling of existing positions. Such a ratio is uncommon on expiry day and points to aggressive directional bets being placed in the final hours. The relatively modest open interest compared to the volume traded suggests that traders are either initiating new bullish positions or rolling over short positions into calls. does this surge in fresh call buying signal a confident short-term directional stance?

Cash Market Context and Technical Indicators

Divis Laboratories Ltd is trading comfortably above its key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — which collectively indicate a strong uptrend. The stock’s narrow trading range of Rs 3.5 on the day suggests consolidation near resistance, while the 1.25% gain outpaced the sector’s 0.15% rise and the Sensex’s 0.28% decline. This alignment between the derivatives and cash markets reinforces the interpretation that the call activity is supported by underlying price momentum. However, delivery volumes tell a slightly different story: volumes fell by 6.15% compared to the 5-day average, with 1.64 lakh shares delivered on 24 Aug. This divergence between rising call activity and falling delivery volumes raises the question of whether the derivatives market is leading the cash market or if the rally is yet to be fully confirmed by investor participation — is this a temporary disconnect or a warning sign?

Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!

  • - Recent Momentum qualifier
  • - Stellar technical indicators
  • - Large Cap fast mover

Strike Now - View Stock →

Delivery Volume and Liquidity Considerations

Despite the strong call option activity, delivery volumes have declined modestly, with 1.64 lakh shares delivered on 24 Aug, down 6.15% from the 5-day average. This suggests that while the derivatives market is showing heightened interest, the cash market participation is somewhat subdued. The stock remains liquid enough to handle trades worth approximately ₹4.7 crores based on 2% of the 5-day average traded value, indicating that liquidity constraints are unlikely to be a factor in the observed activity. The falling delivery volume amid rising call contracts could imply that traders are expressing bullishness through options rather than outright stock purchases — does this divergence hint at a cautious approach among cash investors?

Key Data at a Glance

Strike Price
Rs 8,700
Contracts Traded
7,999
Open Interest
1,090
Underlying Price
Rs 8,599.50
Turnover
₹87.03 lakhs
Expiry Date
25 Aug 2026
Day Change (Stock)
+1.25%
Delivery Volume
1.64 lakh (down 6.15%)

Curious about Divis Laboratories Ltd from Pharmaceuticals & Biotechnology? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!

  • - Detailed research coverage
  • - Technical + fundamental view
  • - Decision-ready insights

Get the Complete Analysis →

Collective Interpretation of Options and Cash Market Signals

The concentrated call buying at the Rs 8,700 strike, just above the current stock price, combined with a high contracts-to-open interest ratio, points to fresh and urgent bullish positioning ahead of expiry. The stock’s strong technical backdrop, trading above all major moving averages and near its 52-week high, supports this directional conviction. However, the slight decline in delivery volumes tempers the enthusiasm, suggesting that cash market investors may be more cautious or awaiting confirmation before committing fully. The options market appears to be leading the charge, expressing a near-term directional bet that the stock will either break through resistance or test it decisively — buy, sell, or hold: how should one interpret this mixed signal in Divis Laboratories Ltd?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News